Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2050 of 3546 entries
View as:

Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

Phase: N/A Priority: Normal
NCT ID: NCT00611559 Org: User:
Start: 02/14/08 End: 06/25/08 Due: 06/25/09

This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama

Phase: N/A Priority: Normal
NCT ID: NCT02712359 Org: User:
Start: 06/01/16 End: 08/22/18 Due: 08/22/19

ADOAIR250 Anti-inflammatory Effects in Japanese Subjects With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01607398 Org: User:
Start: 05/31/12 End: 07/31/13 Due: 07/31/14

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.

Phase: N/A Priority: Normal
NCT ID: NCT00707967 Org: User:
Start: 06/30/08 End: 05/27/09 Due: 05/27/10

Exploratory Study in Healthy Elderly Subjects to Collect Urine for Development of Assays to Detect S. Pneumoniae

Phase: N/A Priority: Normal
NCT ID: NCT00523770 Org: User:
Start: 09/30/07 End: - Due: -

PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011

Phase: N/A Priority: Normal
NCT ID: NCT02039960 Org: User:
Start: 11/30/13 End: 01/31/14 Due: 01/31/15

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00935831 Org: User:
Start: 08/12/09 End: 04/27/10 Due: 04/27/11

Efficacy of Manual Toothbrushes in Removing Dental Plaque

Phase: N/A Priority: Normal
NCT ID: NCT04025684 Org: User:
Start: 09/30/19 End: 12/10/19 Due: 12/10/20

Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01657526 Org: User:
Start: 08/08/12 End: 11/25/13 Due: 11/25/14

Subject Insights to Understand the Hand Osteoarthritis (HOA)

Phase: N/A Priority: Normal
NCT ID: NCT03271203 Org: User:
Start: 07/03/17 End: 10/30/17 Due: 10/30/18

Prospective Sexual Function Study for BPH Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01777269 Org: User:
Start: 02/18/13 End: 04/05/16 Due: 04/05/17

A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)

Phase: N/A Priority: Normal
NCT ID: NCT00094367 Org: User:
Start: 07/31/04 End: 10/31/05 Due: 10/31/06

A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL)

Phase: N/A Priority: Normal
NCT ID: NCT01573000 Org: User:
Start: 09/30/98 End: 04/30/10 Due: 04/30/11

A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children

Phase: N/A Priority: Normal
NCT ID: NCT01218308 Org: User:
Start: 12/09/10 End: 01/09/12 Due: 01/09/13

A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT05446740 Org: User:
Start: 08/09/22 End: 03/26/24 Due: 03/26/25

A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03201978 Org: User:
Start: 12/14/17 End: 05/15/18 Due: 05/15/19

Regulatory Nebilet PMS

Phase: N/A Priority: Normal
NCT ID: NCT01077661 Org: User:
Start: 10/31/09 End: 01/31/11 Due: 01/31/12

Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT00964106 Org: User:
Start: 08/26/09 End: 08/29/11 Due: 08/29/12

Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD

Phase: N/A Priority: Normal
NCT ID: NCT00749411 Org: User:
Start: 11/13/08 End: 02/12/09 Due: 02/12/10

A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02688387 Org: User:
Start: 03/18/16 End: 08/04/17 Due: 08/04/18

Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01797926 Org: User:
Start: 05/23/13 End: 07/25/13 Due: 07/25/14

The Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT00453791 Org: User:
Start: 02/07/06 End: 04/10/06 Due: 04/10/07

Boostrix® Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT02096276 Org: User:
Start: 03/31/14 End: 08/02/19 Due: 08/02/20

A Validation and Dosimetry Study of GSK2634673F PET Ligand

Phase: N/A Priority: Normal
NCT ID: NCT02052297 Org: User:
Start: 01/24/14 End: 04/21/16 Due: 04/21/17

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01696604 Org: User:
Start: 09/26/12 End: 05/03/13 Due: 05/03/14